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Weight loss lowers 
LDL-C, although 
some studies  
suggest it may  
be short-term
Consider patient preference 
when discussing lifestyle modification
Therapeutic	lifestyle	changes	are	the	
initial	treatment	of	choice	for	reduction	of	
cardiac	risk	factors,	but	both	patients	and	
physicians	often	see	these	modifications	
as	confusing	and	difficult	to	achieve.	A	
recent	year-long	study	on	different	diets	
concluded	that	dietary	adherence	is	more	
important	than	a	specific	type	of	diet	for	
weight	loss	and	reduction	of	cardiac	risk	
factors.1	Another	recent	study	reports	no	
difference	in	weight	loss	among	diets,	
based	on	different	exercise	duration	
and	intensities	over	1	year	in	a	group	
of	sedentary	and	overweight	women.2	
Therefore,	family	physicians	should	
consider	culture,	patient	preference,	
and	practical	issues	such	as	cost	and	
availability,	when	discussing	therapeutic	
lifestyle	modification	with	patients.
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Counseling,	weight	loss,	exercise,	and	
drinking	alcohol	all	effectively	lower		
low-density	lipoprotein	cholesterol		
(lDl-C).	specifically,	one	to	2	daily	drinks	
of	alcohol	lowers	lDl-C,	if	consumed	
regularly	for	more	than	4	weeks	
(strength	of	recommendation	[sor]:	A,	
based	on	consistent	results	of	multiple	
randomized	controlled	trials	[rCTs]).	
	 Counseling	by	physicians,	
dieticians,	or	pharmacists	is	effective	
at	increasing	patient	compliance	with	
medications,	thereby	lowering	lDl-C	
(sor:	C,	good	evidence	that	intervention	
lowers	lDl-C,	insufficient	to	prove	
that	it	reduces	mortality/morbidity).	
	 Weight	loss	has	been	associated	
with	reductions	in	lDl-C.	However,	
other	factors—including	degree	of	
caloric	restriction,	drug	intervention,	
and	diet	composition—may	play	a	more	
significant	role	than	weight	loss	alone	
(sor:	A,	based	on	a	meta-analysis	
and	consistent	results	of	rCTs).
	 exercise	significantly	lowers	lDl-C	
(sor:	A,	based	on	meta-analyses		
and	consistent	results	of	rCTs).	smoking	
cessation	may	have	a	beneficial	effect	
(sor:	B,	based	on	inconsistent	results	
from	rCTs	that	it	lowers	lDl-C).	exercise-
based	alternative	practices	(yoga	and	
tai	chi)	lower	lDl,	and	meditation	
may	have	a	beneficial	effect	(sor:	C,	
moderate	evidence	that	intervention	
lowers	lDl,	insufficient	evidence	to	prove	
that	it	reduces	mortality/morbidity).	
Evidence-based answer
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Which lifestyle interventions  
effectively lower  
LDL cholesterol?
CoNT INueD
Copy
right
® Dow
den H
ealth
 Med
ia  
For p
erson
al us
e onl
y
For mass reproduction, content licensing and permissions contact Dowden Health Media.
fast track
484 vol	56,	No	6	/	juNe	2007		ThE JournAl of fAmily PrACTiCE
C
l
in
iC
a
l
 I
N
q
u
Ir
Ie
s
2 clinical trials 
found that LDL 
decreased  
significantly with  
1 to 2 alcohol 
drinks per day
z Evidence summary
Elevated LDL-C is an independent 
risk factor for coronary heart disease 
(CHD),3 the leading cause of death in 
the US.4 Lowering LDL-C by 60 mg/dL 
reduces CHD events by 50% after 2 
years.5 Although medications success-
fully lower LDL-C and decrease CHD 
risk, therapeutic lifestyle changes re-
main the initial therapy for most adult 
patients.3,6 
Our search located evidence about 
alcohol consumption, counseling, ex-
ercise, weight loss, alternative lifestyle 
measures, and smoking cessation. The 
TabLE summarizes the evidence for 
each. 
1 to 2 drinks daily reduced LDL-C
One 5-year-long cohort study (N=933) 
showed that alcohol was associated with 
LDL-C reduction in a dose-dependent 
manner.7 Two crossover trials (4–6 weeks 
in duration) conducted among heavy 
drinkers showed that LDL-C increased 
when alcohol intake decreased. Two ran-
domized crossover trials (8–12 weeks in 
duration) found a statistically significant 
decrease in LDL-C with consumption of 
1 to 2 drinks daily. 
Counseling improves  
medication adherence
An RCT (N=167) with 8 years of fol-
low-up found that patient education and 
counseling effectively improved medica-
tion adherence.8 Another RCT (N=1162) 
lasting 1 year, however, found that nutri-
tion counseling by primary care physi-
cians resulted in no significant change in 
LDL-C compared with usual care.9 
Studies focused on enhancing dietary 
compliance did not find consistent post- 
intervention improvement. Greater medi-
cation adherence or improved dietary 
compliance did result in consistent signifi-
cant improvements in LDL-C. 
Exercise lowers LDL;  
weight loss a factor
Aerobic exercise effectively lowers LDL-
C. This reduction is enhanced by weight 
loss and diet and mitigated by weight 
gain.10 An analysis of 4 RCTs showed 
that LDL-C also decreased with resis-
tance training. 
A higher body-mass index is associ-
ated with higher LDL-C. However, the 
effect of weight loss per se on LDL-C re-
mains unclear. Multiple short-term stud-
ies have found that a modest amount of 
tablE
a- and b-level evidence points to effectiveness  
of lifestyle interventions
lifEsTylE mAgniTudE of % rEduCTion  dATA   
inTErvEnTion  EffECT on ldl-C ldl-C sourCEs sor
Alcohol	 4–10	mg/dl	 4%–8%	 4	rCTs	 A
Counseling	 0–58	mg/dl	 0%–33%	 15	rCTs,	8	CTs	 A
exercise	 3–16	mg/dl	 2.5%–4%	 5	meta-analysis		 A
Meditation	 0–28	mg/dl	 0%–19%	 3	rCTs	 B
smoking	 0–5	mg/dl	 0%–4%	 2	rCTs	 B
Weight	loss:	
	 –	diet,	exercise,		 0–42	mg/dl	 0%–22%	 28	rCTs,	14	CTs,		 	
	 			supplements	 	 	 1	meta-analysis	
	 –	drug	therapy	 10–31	mg/dl	 11%–32%		 4	rCTs,	2	CTs
Yoga/tai	chi	 20–26	mg/dl	 15%–20%	 2	rCTs,	1	CT	 A
lDl-C,	low-density	lipoprotein	cholesterol;	sor,	strength	of	recommendation;		
rCT,	randomized	controlled	trial;	CT,	clinical	trials.
sor:	A,	good	evidence	that	intervention	lowers	lDl.	sor:	B,	moderate	evidence.
A
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weight loss (5%–10%) is associated with 
a significant reduction in LDL-C.11 A 
meta-analysis found a 0.8 mg/dL LDL-C 
decrease for every kg of weight lost. Long-
term follow-up, however, showed that 
LDL-C returned to baseline even when 
weight loss was maintained. Eight clinical 
trials failed to demonstrate a reduction in 
LDL-C postintervention with up to 10 kg 
of weight loss. Studies using weight-loss 
drugs (Sibutramine, Orlistat) found more 
significant weight loss during treatment, 
along with greater decrease in LDL-C, 
when compared with studies using only 
lifestyle modifications.
Other measures have mixed results
High-quality RCTs (N=267) with yoga 
or tai chi as the exercise intervention 
showed a statistically significant decrease 
in LDL-C over 12 to 14 weeks.12 Two 
RCTs investigated the effect of medita-
tion on LDL-C with mixed results. One 
(N=16) showed a significant decrease 
in LDL-C over 8 weeks, while a second 
(N=60) showed no difference in LDL-C. 
A high-quality RCT (N=91) with a com-
bined intervention (counseling, exercise, 
and meditation over 1 year) showed a 
significant decrease in LDL-C.
In cross-sectional surveys, LDL-C does 
not appear to differ between smokers and 
nonsmokers. One meta-analysis found 
a dose-dependent relationship between 
smoking and LDL-C, with overall LDL-C 
1.7% higher for smokers compared with 
nonsmokers.13 Two RCTs investigated the 
effect of smoking cessation on LDL-C with 
mixed results. One (N=935) showed a de-
crease in nonfasting LDL-C while a second 
(N=140) showed no difference in LDL-C. 
Recommendations from others 
According to ATP III guidelines,3 all 
adults with LDL-C above goal should be 
treated with therapeutic lifestyle changes 
for primary and secondary prevention of 
CHD. These include a diet intervention, 
increased physical activity, and weight 
loss. Physicians are encouraged to refer 
patients to a nutritionist. If LDL-C is not 
at goal after 6 weeks, changes are intensi-
fied; physicians should consider pharma-
cologic therapy if a patient is still unable 
to attain his or her goal. ACP III guide-
lines recommend an office visit every 4 to 
6 months to monitor adherence. 
American Heart Association guide-
lines recommend that physicians counsel 
smokers at every office visit to stop smok-
ing. The American College of Cardiology 
recommends abstinence from alcohol for 
patients with suspected alcoholic cardio-
myopathy. For patients with heart failure 
from any other cause, alcohol consumption 
is usually limited to 1 drink per day.  n 
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